| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |